Loading…
Cyclerion Therapeutics, Inc. is projected to rise to $4.04 by 2027, a +5% move from its current price of $3.84. CYCN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $3.70 | $3.83 | $3.97 | -0.02% |
| Jul 13 | $3.65 | $3.83 | $4.03 | -0.03% |
| Jul 14 | $3.61 | $3.83 | $4.07 | -0.05% |
| Jul 15 | $3.58 | $3.83 | $4.11 | -0.06% |
| Jul 16 | $3.55 | $3.83 | $4.14 | -0.08% |
| Jul 17 | $3.52 | $3.83 | $4.17 | -0.09% |
| Jul 18 | $3.50 | $3.83 | $4.20 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.50 | $3.83 | $4.20 | -0.11% |
| Week 2 | $3.36 | $3.83 | $4.36 | -0.21% |
| Week 3 | $3.26 | $3.82 | $4.48 | -0.32% |
| Week 4 | $3.18 | $3.82 | $4.59 | -0.42% |
| Week 5 | $3.11 | $3.81 | $4.68 | -0.53% |
| Week 6 | $3.04 | $3.81 | $4.77 | -0.63% |
| Week 7 | $2.99 | $3.81 | $4.85 | -0.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cyclerion Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for serious diseases using novel soluble guanylate cyclase (sGC) stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular sGC stimulator, in Phase 2 clinical trials to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease.
The company has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
CYCN is currently priced at $3.93 with a market cap of $17.02M and a rank of 4979. The near-term price trajectory is reflected in the 2026 forecast as an average of $3.93, with a min of $1.08 and a max of $5.32, yielding 0% ROI and a neutral sentiment.
A major floor 64.8% below — a decisive break under it would weaken the trend.
The nearest floor, 22.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.5% away) — a breakout level to watch.
A major ceiling 66.4% above — clearing it would confirm fresh momentum.
Key CYCN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CYCN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.64 | Buy | $3.68 | Buy |
| MA 10 | $3.51 | Buy | $3.55 | Buy |
| MA 20 | $3.36 | Buy | $3.41 | Buy |
| MA 50 | $3.22 | Buy | $3.18 | Buy |
| MA 100 | $2.71 | Buy | $2.85 | Buy |
| MA 200 | $2.22 | Buy | $2.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 72.77 | Sell |
| Stoch RSI (14) | 77.11 | Neutral |
| CCI (20) | 205.98 | Buy |
| Williams %R (14) | -12.03 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 17.28 | Buy |
| Bollinger %B (20,2) | 1.08 | Sell |
| Stochastic %K (14) | 87.97 | Sell |
| TRIX (15) | 0.42 | Buy |
| Awesome (5,34) | 0.39 | Buy |
| Ultimate (7,14,28) | 78.85 | Sell |
| Momentum (10) | 0.66 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 3.79 | Buy |
| ADX (14) | 21.97 | Buy |
| ATR (14) | 0.08 | Info |
The 30-day technical picture shows a bullish sentiment with RSI14 at 80. The stock is trading above its 50-day moving average of $3.20 and above its 200-day moving average of $2.21, with near-term support at $2.98 and resistance at $3.93.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.08 | $3.84 | $5.18 | 0% | Neutral | |
| $3.14 | $4.04 | $5.56 | +5% | Neutral | |
| $3.27 | $4.36 | $6.27 | +14% | Neutral | |
| $2.86 | $3.93 | $5.86 | +3% | Neutral | |
| $2.91 | $4.12 | $6.32 | +7% | Neutral | |
| $3.56 | $5.17 | $8.13 | +35% | Bullish | |
| $3.88 | $5.76 | $9.28 | +50% | Bullish | |
| $4.13 | $6.26 | $10.29 | +63% | Bullish | |
| $4.20 | $6.50 | $10.89 | +70% | Bullish | |
| $4.09 | $6.48 | $11.03 | +69% | Bullish | |
| $5.59 | $9.71 | $17.78 | +153% | Bullish | |
| $7.15 | $14.67 | $29.83 | +282% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.08 | $3.84 | $4.70 | +0.00% |
| August 2026 | $3.30 | $3.93 | $4.82 | +2.43% |
| September 2026 | $3.15 | $3.78 | $4.70 | -3.70% |
| October 2026 | $3.14 | $3.80 | $4.78 | +0.41% |
| November 2026 | $3.28 | $3.99 | $5.07 | +5.04% |
| December 2026 | $3.30 | $4.04 | $5.18 | +1.21% |
Click any year to see its month-by-month CYCN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CYCN could reach as high as $5.18, with a base case around $3.84 and support toward $1.08 — roughly 0% from $3.84. Price action looks broadly range-bound.
Expect CYCN to range from $3.14 to $5.56 through 2027. The $4.04 average target implies a +5% move from current prices. That is up +5% on the projected 2026 average. A consolidation phase looks the most probable path here.
The CYCN price prediction for 2028 points to an average of $4.36 (low $3.27, high $6.27) — a potential gain of +14% on today's $3.84. Price action looks broadly range-bound.
In 2029, CYCN is projected to trade between $2.86 and $5.86, averaging $3.93 — a potential gain of +3% from today's $3.84. That is -10% versus the projected 2028 average. A consolidation phase looks the most probable path here.
Cyclerion Therapeutics, Inc.'s 2030 outlook centres on $4.12, within a $2.91 to $6.32 range. That is up +5% on the projected 2029 average. That marks a +7% change versus current levels. Price action looks broadly range-bound.
By 2031, CYCN could reach as high as $8.13, with a base case around $5.17 and support toward $3.56 — roughly +35% from $3.84. Buyers look set to stay in control over this stretch.
Expect CYCN to range from $3.88 to $9.28 through 2032. The $5.76 average target implies a +50% move from current prices. That is up +12% on the projected 2031 average. Momentum favours further upside here.
The CYCN price prediction for 2033 points to an average of $6.26 (low $4.13, high $10.29) — a potential gain of +63% on today's $3.84. Buyers look set to stay in control over this stretch.
In 2034, CYCN is projected to trade between $4.20 and $10.89, averaging $6.50 — a potential gain of +70% from today's $3.84. That is up +4% on the projected 2033 average. Momentum favours further upside here.
Cyclerion Therapeutics, Inc.'s 2035 outlook centres on $6.48, within a $4.09 to $11.03 range. That is 0% versus the projected 2034 average. That marks a +69% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CYCN could reach as high as $17.78, with a base case around $9.71 and support toward $5.59 — roughly +153% from $3.84. Momentum favours further upside here.
Expect CYCN to range from $7.15 to $29.83 through 2050. The $14.67 average target implies a +282% move from current prices. That is up +51% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CYCN today (≈ 260.756193 CYCN) could be worth
$3,824.87
+$2,824.87 (+282%) by 2050 · US Dollar
Based on the average projected CYCN price of $14.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CYCNwould be worth at today's price.
$1,000 invested in CYCN on Jul 10, 2025 (≈ 281.690145 CYCN) would be worth
$1,080.28
+$80.28 (+8.0%) today · 1.08× · US Dollar
Based on a CYCN entry price of $3.55 vs. today's $3.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.43 | $1,118.08 | +11.8% |
| 1 month ago | $3.09 | $1,241.1 | +24.1% |
| 3 months ago | $2.91 | $1,317.87 | +31.8% |
| 6 months ago | $1.71 | $2,242.69 | +124.3% |
| 1 year ago | $3.55 | $1,080.28 | +8.0% |
| All time (5.0y) ago | $76.8 | $49.93 | -95.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CYCN forecast.
Our base-case forecast reaches $7.70 around 2040.
Implied market cap at $7.70: $33.34M
The multi-year forecast presents a rising path in average prices, with 2030 at an average of $4.22 (min $2.97, max $6.51) and a 7.4% ROI, and a bullish trend continuing through 2031–2035 (avg $5.33, $5.93, $6.45, $6.71, $6.65 with ROIs of 35.7%, 51%, 64.2%, 70.7%, and 69.2% respectively). The forecast shows substantial upside later, with 2040 at an average of $10.03 (min $5.71, max $18.51) and a 155.1% ROI, and 2050 at an average of $15.09 (min $7.24, max $30.98) with a 284% ROI. The sentiment remains BULLISH in the later years, though these are estimates and not guarantees of future performance.
Tap a question to reveal the answer.
Average price $4.22; min $2.97; max $6.51; ROI 7.4%; sentiment NEUTRAL.
Forecasts show 0% ROI in 2026, then rising ROIs in later years, with 2031–2050 bullish and ROI reaching 35.7% in 2031, 51% in 2032, 64.2% in 2033, 70.7% in 2034, 69.2% in 2035, and up to 284% by 2050.
Yes, the forecast shows 2040 average at $10.03 and a 2040 max of $18.51; by 2050 the max is $30.98, indicating the potential to exceed $10 in the 2040s.
Current price is $3.93 and market cap is $17.02M.
Average price $15.09 with a max of $30.98 and ROI of 284%; sentiment BULLISH.
Cyclerion Therapeutics, Inc. Community Discussion
0Share your Cyclerion Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.